Adverse effect MonoPoly: Antipsychotic monopharmacy vs antipsychotic polypharmacy in the treatment of schizophrenia

Shaurya Singh, Sonia Shenoy, Samir Kumar Praharaj

Open source

DOI
10.4103/indianjpsychiatry_8_26
Published
2026-08
Container
Indian Journal of Psychiatry
Publisher
Ovid Technologies (Wolters Kluwer Health)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.4103/indianjpsychiatry_8_26,
  title = {Adverse effect MonoPoly: Antipsychotic monopharmacy vs antipsychotic polypharmacy in the treatment of schizophrenia},
  author = {Shaurya Singh and Sonia Shenoy and Samir Kumar Praharaj},
  year = {2026},
  journal = {Indian Journal of Psychiatry},
  doi = {10.4103/indianjpsychiatry_8_26},
  url = {https://doi.org/10.4103/indianjpsychiatry_8_26}
}

RIS

TY  - JOUR
TI  - Adverse effect MonoPoly: Antipsychotic monopharmacy vs antipsychotic polypharmacy in the treatment of schizophrenia
AU  - Shaurya Singh
AU  - Sonia Shenoy
AU  - Samir Kumar Praharaj
PY  - 2026
JO  - Indian Journal of Psychiatry
DO  - 10.4103/indianjpsychiatry_8_26
UR  - https://doi.org/10.4103/indianjpsychiatry_8_26
ER  - 

APA

Singh, S., Shenoy, S., & Praharaj, S. K. (2026). Adverse effect MonoPoly: Antipsychotic monopharmacy vs antipsychotic polypharmacy in the treatment of schizophrenia. Indian Journal of Psychiatry. https://doi.org/10.4103/indianjpsychiatry_8_26

Source records